Repros Therapeutics Inc. Reports Third Quarter 2007 Financial Results and Provides Clinical Development Update

THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics (NasdaqGM:RPRX) today announced financial results for the three-month and nine-month periods ended September 30, 2007 and provided an update on the Company’s ongoing clinical programs.